Cyclacel reports preclinical data of CYC065 for treatment of cancer, other serious diseases
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of …
Read more on News-Medical-Net
Dr. Gott: Antibodies attack good cells, causing pemphigus – Tue, 07 Dec 2010 PST
DEAR DR. GOTT: How do you get pemphigus vulgaris? My young relative has been diagnosed with this condition. He has been sick since November 2009 and can’t seem to get well. What should we expect? DEAR READER: Pemphigus is a rare autoimmune skin disorder that causes skin or mucus-membrane blisters of the mouth or genitals that tend to rupture easily, leaving open lesions that can become infected …
Read more on The Spokesman-Review
Recommended Items for:Skin Cancer
Skin Cancer 
The ultimate all-in-one guide to diagnosing and treating skin cancer A Doody’s Core Title ESSENTIAL PURCHASE! 4 STAR DOODY’…
Skin Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. Everything You Need to Know About Skin Cancer This book is for people who have skin cancer, as well as for their family members, friends, students, and others who want to find …
M-Edge Prodigy Leather Kindle Jacket with Hinge (Fits 6″ Display, 2nd Generation Kindle), Pink The Prodigy Jacket for 2nd Generation Kindle is the ultimate for sophisticated on-the-go e-reader users. Whether in the office, at…
Related Topics
Tags: Cancer, CYC065, Cyclacel, Data, diseases, preclinical, reports, serious, TREATMENT